June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Pharmacological modulation of Toll-like receptor-stimulated downstream inflammatory pathways in an experimental model of uveitis.
Author Affiliations & Notes
  • Moksha Laxmi
    OCULAR PHARMACOLOGY AND PHARMACY DIVISION, RP CENTRE, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Nabanita Halder
    OCULAR PHARMACOLOGY AND PHARMACY DIVISION, RP CENTRE, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Atul kumar
    Ophthalmology, Dr RP Centre, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Baskar S. Singh
    Biophysics, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Rohan Chawla
    Ophthalmology, Dr RP Centre, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Thirumurthy Velpandian
    OCULAR PHARMACOLOGY AND PHARMACY DIVISION, RP CENTRE, All India Institute of Medical Sciences, New Delhi, Delhi, India
  • Footnotes
    Commercial Relationships   Moksha Laxmi None; Nabanita Halder None; Atul kumar None; Baskar Singh None; Rohan Chawla None; Thirumurthy Velpandian None
  • Footnotes
    Support  Council of Scientific & Industrial Research-India for Research Associate fellowship
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3523. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Moksha Laxmi, Nabanita Halder, Atul kumar, Baskar S. Singh, Rohan Chawla, Thirumurthy Velpandian; Pharmacological modulation of Toll-like receptor-stimulated downstream inflammatory pathways in an experimental model of uveitis.. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3523.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Toll-like receptor (TLR) acting as lipopolysaccharide (LPS) sensor is involved in recognition of and response to endotoxin mediated infections. Their activation contributes to uveitis leading to stimulation of signaling events that include expressions of various cytokines such as TNF-α. The mainstay for the treatment is steroids, which are substrates for P-gp transporters, and on topical application, would be effluxed, leading to insufficient therapeutic levels in aqueous humor (AH). Hence, this study evaluated alternative P-gp sparing molecules that act via similar anti-inflammatory pathways to control inflammation.

Methods : Topical dapsone and nimesulide (0.1%) were formulated aseptically and evaluated in endotoxin-induced uveitis (EIU) Wistar rat model in comparison with topical prednisolone (1%). Rats received 0.1 ml saline containing 200 µg LPS through hindpaw, with three times a day (TID) topical instillation of 10 µl vehicle, nimesulide, dapsone and prednisolone (Table 1) in their respective groups. 30 µl of AH was collected for protein extravasation analysis and TNF-α levels.

Results : Results showed topical nimesulide significantly reduced AH TNF-α levels in EIU (Nimesulide) group (14.07±5.36 ng/ml) as compared to EIU (Vehicle) group (40.6±5.51 ng/ml). It also reduced protein leakage in AH of EIU (Nimesulide) group (8.37±2.87 mg/ml) as compared to control (18.48±2.13 mg/ml). The topical dapsone resulted in a significant decrease in total protein concentration of AH in EIU (Dapsone) group (11.44±0.93 mg/ml) when compared to EIU (Vehicle) group (22.5±2.06 mg/ml). Moreover, 0.1% dapsone topical instillation also decreased TNF-α levels in AH of EIU (Dapsone) group (18.4±2.26 ng/ml) when compared to EIU (Vehicle) group (26.49±3.66 ng/ml). While prednisolone administered (TID) in EIU showed non-significant reduction in total protein as well as TNF-α levels in AH.

Conclusions : For the first time, sterile topical nimesulide and dapsone formulations were developed and were found to be effective in modulating TLR by reducing inflammatory markers (TNF-α) and vascular leakage in AH of rats when compared to prednisolone. Therefore, this study showed that molecules that are P-gp sparing could be a better option for targeting TNF-α pathway for their utility in uveitis.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

Table 1: Groups used for the Pharmacological evaluation of TNF alpha modulators (n=5 in each group)

Table 1: Groups used for the Pharmacological evaluation of TNF alpha modulators (n=5 in each group)

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×